RNA干渉技術市場：タイプ別、治療薬別、用途別-2024-2030年の世界予測

RNA干渉技術市場規模は、2023年に329億2,000万米ドルと推定され、2024年には392億5,000万米ドルに達し、CAGR 22.38%で2030年には1,354億米ドルに達すると予測されています。

RNA干渉（RNAi）技術市場には、低分子RNAを用いて遺伝子発現を制御するシステムが含まれます。この技術は、機能ゲノミクス、治療開発、害虫駆除のための農業に応用できます。この市場には、試薬、siRNA、shRNA、マイクロRNAなどの様々な関連製品や、RNAiベースの研究開発のためのサービスが含まれます。RNAi技術市場の成長に影響を与える主な要因としては、遺伝子治療の進歩や遺伝性疾患の有病率の増加が挙げられます。さらに、創薬・開発プロセスへの投資の高まりもRNAiを後押ししています。RNAi技術市場は大きな成長の可能性を秘めているが、RNAi分子を標的細胞に効果的に送達することの難しさや、体内での安定性の確保など、顕著な限界や課題もあります。意図しない遺伝子サイレンシングのリスクがあり、オフターゲット効果や潜在的な毒性につながります。しかしながら、遺伝子治療の進歩や遺伝性疾患の有病率の増加。RNAiによる創薬・開発プロセスへの投資の増加。

タイプ：siRNAの標的遺伝子治療への利用による多くの疾患の治療

dsRNAはRNAi経路の前駆体分子として働き、細胞の機械によって認識され、より小さなRNAi効果のある分子に加工されます。miRNAは、植物、動物、および一部のウイルスに見られる小さなノンコーディングRNA分子で、RNAサイレンシングと遺伝子発現の転写後調節に機能します。siRNAは、通常20～25塩基対の長さの二本鎖RNA分子の一種で、相補的な塩基配列を持つ特定の遺伝子の発現を阻害します。siRNAは、mRNAレベルでの遺伝子異常を標的とし、その発現を抑制するため、特に遺伝子治療において、薬剤開発の重点分野となっています。dsRNAの安定した性質と幅広い活性は、農業での使用やウイルス防御研究の初期段階に有利であり、一方miRNAの遺伝子制御における役割は、複雑な疾患の治療や診断に有望です。

応用創薬と開発におけるRNA干渉技術の急速な普及

創薬および薬剤開発におけるRNAiは、主に遺伝子の機能を同定し、薬剤ターゲットを検証するために使用されます。RNAiは、研究者が可逆的かつ高度に特異的な方法で遺伝子を効率的に沈黙させることを可能にし、特定の遺伝子がどのように疾患に関与しているかを同定することを容易にします。RNAi技術は、治療薬の分野では病気の原因となる遺伝子を沈黙させるために直接応用されています。これにより、特に単一遺伝子の突然変異によって引き起こされる疾患や、従来の低分子医薬品や生物製剤が無効であった疾患に対する新薬が開発されています。RNAiの治療応用は、ある種のがん、ウイルス感染、遺伝性遺伝性疾患など、遺伝的基盤がわかっている疾患に好んで用いられます。

地域別インサイト

南北アメリカでは、RNA干渉（RNAi）技術は、特にバイオテクノロジーと製薬の分野で著しい進歩を遂げています。この分野では米国がリードしており、イノベーションを推進する企業や研究機関の存在感が強いです。米国国立衛生研究所（NIH）による取り組みや、RNAiに特化したバイオテクノロジーハブ内での共同研究が、さらなる研究開発を促進しています。さらに、ベンチャーキャピタルは、がん治療から遺伝性疾患に至るまで、さまざまな医療用途で遺伝子サイレンシングにRNAiを活用する新興企業への出資を増やしています。EMEA（欧州・中東・アフリカ）地域は、RNAi技術の多様な状況を示しており、欧州が臨床開発と研究の主導権を握っています。ドイツのSilence Therapeutics社やCureVac社などの欧州のバイオテクノロジー企業は、RNAiベースの治療薬の発展に貢献してきました。さらに、欧州医薬品庁（EMA）はRNAi医薬品の承認に強固な枠組みを提供しており、この分野の成長をさらに促進しています。欧州連合（EU）からの様々なフレームワーク・プログラムによる資金援助を受けている生物医学研究コミュニティは、RNAiの理解と応用に貢献し続けています。中東・アフリカ市場では、技術ギャップを埋め、地域特有の疾病に取り組むRNAiの可能性を探ろうと躍起になっている学術機関を中心に、活動が活発化しています。アジア太平洋地域は、技術革新と市場拡大に重点を置き、RNAi技術の急速な成長を示しています。日本と中国は、バイオテクノロジー研究と急速に発展する製薬部門への投資により、この成長の最前線にいます。政府のイニシアチブと国際的なバイオテクノロジー企業との協力が業界の成長に大きく寄与しており、学術研究機関がRNAiメカニズムに関する基礎的な洞察を提供しています。加えて、この地域の国際共同治験への参加が増加していることは、RNAi治療薬をヘルスケアシステムに組み込むことへのコミットメントを示しています。この統合は、APACのダイナミックな規制状況によって促進され、進化する科学的状況に対応しようと努力しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、RNA干渉技術市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、RNA干渉技術市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.RNA干渉技術市場の市場規模および予測は？

2.RNA干渉技術市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.RNA干渉技術市場の技術動向と規制枠組みは？

4.RNA干渉技術市場における主要ベンダーの市場シェアは？

5.RNA干渉技術市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 遺伝性疾患と慢性疾患の世界の増加
    • 創薬と開発におけるRNAi技術の応用拡大
    • 分子診断の必要性の高まり
  • 抑制要因
    • RNAi療法に関する厳格なFDA規制
  • 機会
    • ナノテクノロジーとがんの分野における進行中の研究開発
    • 開発中の最先端のRNAi療法
  • 課題
    • RNA干渉療法の実施に関する懸念
• 市場セグメンテーション分析
  • タイプ：さまざまな疾患の治療のための標的遺伝子治療におけるsiRNAの使用
  • アプリケーション：薬物の発見と開発のためのRNA干渉技術の急速な採用
• 市場動向分析
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析
• 顧客のカスタマイズ

第6章 RNA干渉技術市場：タイプ別

• 二本鎖RNA
• マイクロRNA
• siRNA

第7章 RNA干渉技術市場セラピューティクス

• 自己免疫性肝炎
• B型肝炎とC型肝炎
• 神経学的障害
• 腫瘍学
• 呼吸器疾患

第8章 RNA干渉技術市場：用途別

• 医薬品の発見と開発
• 治療薬

第9章 南北アメリカのRNA干渉技術市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のRNA干渉技術市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのRNA干渉技術市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • スイッチ・セラピューティクス、5,200万米ドルを調達して初のRNAi技術を開発
  • アルニラム・ファーマシューティカルズとメディソン・ファーマは、RNAi治療薬の商業化に向けて、協力関係を複数地域にわたるパートナーシップに拡大することを発表

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. RNA INTERFERENCE TECHNOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. RNA INTERFERENCE TECHNOLOGY MARKET DYNAMICS
• FIGURE 7. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. RNA INTERFERENCE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. RNA INTERFERENCE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RNA INTERFERENCE TECHNOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DSRNA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DSRNA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MIRNA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MIRNA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SIRNA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SIRNA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY AUTOIMMUNE HEPATITIS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY AUTOIMMUNE HEPATITIS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HEPATITIS B AND C, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HEPATITIS B AND C, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 39. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 40. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 41. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 42. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 43. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 44. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 45. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 46. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 47. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 48. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 49. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 50. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 51. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 52. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 53. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 54. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 55. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 56. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 57. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 58. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 59. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 60. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 61. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 62. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 63. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 64. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 65. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 66. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 69. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 70. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 71. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 72. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 74. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 78. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 80. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 81. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 82. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 83. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 84. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 85. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 86. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 87. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 88. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 89. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 90. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 91. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 92. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 93. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 94. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 95. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 96. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 97. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 98. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 99. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 100. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 101. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 102. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 103. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 104. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 105. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 106. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 107. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 108. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 109. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 110. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 111. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 112. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 113. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 114. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 115. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 116. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 117. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 118. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 119. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 120. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 121. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 122. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 123. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 124. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 125. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 126. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 127. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 128. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 130. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 132. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 134. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 135. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 136. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 137. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 138. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 139. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 140. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 141. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 142. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 143. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 144. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 145. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 146. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 147. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 148. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 149. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 150. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 151. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 152. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 161. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 162. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 163. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 164. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 165. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 166. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 167. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 168. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 169. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 170. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 171. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 172. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 173. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 174. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 175. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 176. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 177. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 178. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 179. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 180. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 181. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 182. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 183. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 184. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 185. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 186. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 187. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 188. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 189. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 190. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 191. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 192. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 193. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 194. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 195. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 196. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 197. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 198. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 199. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 200. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 201. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 202. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 203. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 204. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 205. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 206. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 207. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 208. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 209. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 210. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 211. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 212. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 213. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 214. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 215. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 216. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 217. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 218. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 219. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 220. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 221. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 222. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 223. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 224. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 225. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 226. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 227. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 228. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 229. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 230. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 231. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 232. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 233. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 234. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 235. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 236. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 237. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 238. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 240. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 242. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 244. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 248. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 250. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 251. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 252. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 253. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 254. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 255. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 256. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 257. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 258. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 259. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 260. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 261. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 262. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 263. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 264. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 265. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 266. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 267. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 268. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 269. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 270. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 271. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 272. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 273. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 274. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 282. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
• TABLE 284. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 286. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 287. RNA INTERFERENCE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 288. RNA INTERFERENCE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

[195 Pages Report] The RNA Interference Technology Market size was estimated at USD 32.92 billion in 2023 and expected to reach USD 39.25 billion in 2024, at a CAGR 22.38% to reach USD 135.40 billion by 2030.

The RNA interference (RNAi) technology market encompasses systems that use small RNA molecules to regulate gene expression. This technology is applicable in functional genomics, therapeutic developments, and agriculture for pest control. It encompasses various related products such as reagents, siRNA, shRNA, and microRNA and services for RNAi-based research and development. The key factors influencing the growth of the RNAi technology market include advancements in gene therapy and the increasing prevalence of genetic disorders. Additionally, rising investments in drug discovery and development processes are driven by RNAi. While the RNAi technology market presents significant growth potential, there are notable limitations and challenges, including difficulty in delivering RNAi molecules effectively to targeted cells and ensuring their stability within the body. Risk of unintended gene silencing, leading to off-target effects and potential toxicity. However, advancements in gene therapy and the increasing prevalence of genetic disorders. Rising investments in drug discovery and development processes driven by RNAi.

Type: siRNA's use for targeted gene therapy for treating a multitude of diseases

dsRNA acts as the precursor molecule in the RNAi pathway and is recognized by the cell's machinery to be processed into smaller RNAi-effective molecules. It triggers a natural defense mechanism against RNA viruses and is used in various applications, including agricultural biotechnology and therapeutic developments. miRNA is a small non-coding RNA molecule found in plants, animals, and some viruses, which functions in RNA silencing and post-transcriptional regulation of gene expression. Research into miRNA has surged due to its role in regulating cellular functions and implications in various diseases, including cancer. siRNA is a class of double-stranded RNA molecules, typically 20-25 base pairs in length that interfere with the expression of specific genes with complementary nucleotide sequences. siRNA has been a focus area for drug development, notably in gene therapy, to target and silence genetic abnormalities at the mRNA level. dsRNA's stable nature and broad-spectrum activity make it favorable for agricultural use and the initial stages of viral defense research, while miRNA's role in gene regulation offers promise for complex disease therapy and diagnostics. siRNA's high specificity and reduced off-target effects position it as a frontrunner in targeted gene therapy for many diseases.

Application: Exponential adoption of RNA interference technology for dru discovery & development

The RNAi in drug discovery and development is primarily used to identify the function of genes and validate drug targets. RNAi allows researchers to efficiently silence genes in a reversible and highly specific manner, which facilitates identifying how particular genes contribute to disease. RNAi technology is applied directly to silence disease-causing genes in the therapeutics segment. This has led to the development of new medicines, particularly for diseases caused by single-gene mutations or where traditional small-molecule drugs or biologics have been ineffective. Therapeutic application of RNAi is preferred for diseases with known genetic bases, such as certain types of cancer, viral infections, and inherited genetic disorders.

Regional Insights

In the Americas, RNA interference (RNAi) technology has seen significant advancement, particularly within the biotechnology and pharmaceutical sectors. The United States leads in this space, with a strong presence of companies and research institutions driving innovation. Initiatives by the National Institutes of Health (NIH) and collaborations within RNAi-focused biotech hubs promote further research and development. Additionally, venture capital is increasingly funding startups that leverage RNAi for gene silencing in various medical applications, ranging from cancer therapy to genetic disorders. The EMEA region shows a diverse landscape for RNAi technology, with Europe taking the lead in clinical development and research. European biotech companies, such as Silence Therapeutics and CureVac in Germany, have been instrumental in advancing RNAi-based therapeutics. Moreover, the European Medicines Agency (EMA) provides a robust framework for RNAi drug approval, further facilitating growth in this domain. The biomedical research community, supported by funding from the European Union through various Framework Programmes, continues to contribute to the understanding and application of RNAi. Activity within the Middle East and African markets is emerging, with research primarily driven by academic institutions eager to bridge the technology gap and explore RNAi's potential in tackling region-specific diseases. The Asia-Pacific region demonstrates rapid growth in RNAi technology with a strong emphasis on innovation and market expansion. Japan and China are at the forefront of this growth due to their investments in biotechnology research and quickly evolving pharmaceutical sectors. Government initiatives and collaborations with international biotech firms have significantly contributed to the industry's growth, with academic research institutions providing foundational insights into RNAi mechanisms. Additionally, the region's increasing participation in global clinical trials exhibits a commitment to integrating RNAi therapeutics into their healthcare systems. This integration is facilitated by APAC's dynamic regulatory environment, striving to keep pace with the evolving scientific landscape.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the RNA Interference Technology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the RNA Interference Technology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the RNA Interference Technology Market, highlighting leading vendors and their innovative profiles. These include Alnylam Pharmaceuticals, Inc., AMSBIO, Arbutus Biopharma Corporation, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals, Inc., AstraZeneca PLC, Atalanta Therapeutics, Bioneer Corporation, CureVac N.V., Dicerna Pharmaceuticals, Inc., Gotham Therapeutics Corp., Gradalis, Inc., Ionis Pharmaceuticals, Inc., Merck KGaA, NeuBase Therapeutics, Inc., Novartis AG, Nutcracker Therapeutics, Inc., Phio Pharmaceuticals Corp., ProQR Therapeutics N.V., Sanofi S.A., Silence Therapeutics PLC, Sirnaomics, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the RNA Interference Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • dsRNA
  • miRNA
  • siRNA

• Therapeutics
  • Autoimmune Hepatitis
  • Hepatitis B and C
  • Neurological Disorders
  • Oncology
  • Respiratory Disorders

• Application
  • Drug Discovery and Development
  • Therapeutics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the RNA Interference Technology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the RNA Interference Technology Market?

3. What are the technology trends and regulatory frameworks in the RNA Interference Technology Market?

4. What is the market share of the leading vendors in the RNA Interference Technology Market?

5. Which modes and strategic moves are suitable for entering the RNA Interference Technology Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Prevalence of Genetic and Chronic Disorders Globally
    • 5.1.1.2. Increasing Application of RNAi Technology in Drug Discovery & Development
    • 5.1.1.3. Growing Need for Molecular Diagnostics
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent FDA Regulations Regarding RNAi Therapies
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing Research and Development in the Field of Nanotechnology and Cancer
    • 5.1.3.2. State-of-the-art RNAi Therapies in Development
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns in Delivery of RNA-Interference Therapies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: siRNA's use for targeted gene therapy for treating a multitude of diseases
  • 5.2.2. Application: Exponential adoption of RNA interference technology for dru discovery & development
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis
• 5.9. Client Customization

6. RNA Interference Technology Market, by Type

• 6.1. Introduction
• 6.2. dsRNA
• 6.3. miRNA
• 6.4. siRNA

7. RNA Interference Technology Market, by Therapeutics

• 7.1. Introduction
• 7.2. Autoimmune Hepatitis
• 7.3. Hepatitis B and C
• 7.4. Neurological Disorders
• 7.5. Oncology
• 7.6. Respiratory Disorders

8. RNA Interference Technology Market, by Application

• 8.1. Introduction
• 8.2. Drug Discovery and Development
• 8.3. Therapeutics

9. Americas RNA Interference Technology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific RNA Interference Technology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa RNA Interference Technology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Switch Therapeutics Launches with USD 52 Million to Advance First-of-its-Kind RNAi Technology
  • 12.3.2. Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio